| 2025-08-08 | +54.8% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q2 2025 Earnings Call Transcript |
| 2023-12-12 | +43.4% | executive | Seeking Alpha | Nephros CEO buys 18k shares of the company - filing |
| 2022-05-04 | -35.8% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2025-08-07 | +29.3% | earnings | Seeking Alpha | Nephros GAAP EPS of $0.02 beats by $0.05, revenue of $4.4M beats by $0.8M |
| 2026-03-13 | -23.6% | earnings | Motley Fool | Nephros (NEPH) Q4 2025 Earnings Call Transcript |
| 2026-03-13 | -23.6% | earnings | Moby | Nephros, Inc. Q4 2025 Earnings Call Summary |
| 2025-11-07 | -19.2% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q3 2025 Earnings Call Transcript |
| 2025-05-30 | +18.6% | news | Intellectia AI | NEPH Forecast — Price Prediction for 2026. Should I Buy NEPH? - Intellectia AI |
| 2024-03-08 | -18.5% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript |
| 2025-11-06 | -18.2% | earnings | Seeking Alpha | Nephros GAAP EPS of $0.03 beats by $0.05, revenue of $4.8M beats by $0.93M |
| 2026-03-14 | -17.6% | earnings | GuruFocus.com | Nephros Inc (NEPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures |
| 2025-11-26 | -15.5% | legal | SEC EDGAR | NEPH 8-K: 1.01 and 1.02 (SEC Filing) |
| 2025-03-07 | +15.4% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q4 2024 Earnings Call Transcript |
| 2022-05-17 | -15.1% | legal | SEC EDGAR | NEPH 8-K: 8.01 and (SEC Filing) |
| 2025-03-06 | +14.2% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2023-03-08 | -14.0% | earnings | Seeking Alpha | Nephros reports Q4 results |
| 2023-03-08 | -14.0% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2023-05-12 | -14.0% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q1 2023 Earnings Call Transcript |
| 2024-03-07 | -13.3% | earnings | Seeking Alpha | Nephros reports Q4 results |
| 2024-03-07 | -13.3% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2023-02-03 | -11.8% | legal | SEC EDGAR | NEPH 8-K: 5.02 (SEC Filing) |
| 2023-03-09 | -10.9% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q4 2022 Earnings Call Transcript |
| 2024-08-09 | -10.4% | earnings | Seeking Alpha | Nephros GAAP EPS of -$0.03, revenue of $3.3M |
| 2023-08-09 | +10.1% | earnings | Seeking Alpha | Nephros GAAP EPS of -$0.04 beats by $0.02, revenue of $3.5M beats by $0.4M |
| 2023-08-09 | +10.1% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2023-11-06 | +9.9% | legal | SEC EDGAR | NEPH 8-K: 5.02 and (SEC Filing) |
| 2023-11-08 | +9.6% | earnings | Seeking Alpha | Nephros GAAP EPS of -$0.02 beats by $0.05, revenue of $3.74M beats by $0.37M |
| 2023-04-04 | +9.6% | earnings | Seeking Alpha | Nephros gives early look at Q1 numbers |
| 2023-04-04 | +9.6% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | -8.9% | news | GlobeNewswire | Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results |
| 2026-03-12 | -8.9% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q4 2025 Earnings Call Transcript |
| 2026-03-12 | -8.9% | earnings | Seeking Alpha | Nephros GAAP EPS of $0.01 in-line, revenue of $4.7M beats by $0.25M |
| 2025-08-11 | +8.4% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2021-05-06 | -8.0% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2026-02-19 | +7.8% | news | Simply Wall St. | Promising Penny Stocks To Consider In February 2026 |
| 2026-02-19 | +7.8% | news | Simply Wall St. | Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks |
| 2023-08-10 | +7.2% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q2 2023 Earnings Call Transcript |
| 2026-01-07 | -7.1% | news | simplywall.st | Is It Time To Consider Buying Nephros, Inc. (NASDAQ:NEPH)? - simplywall.st |
| 2026-04-16 | -6.6% | news | GlobeNewswire | Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership |
| 2026-04-16 | -6.6% | news | Stock Titan | Aging water systems push Nephros deeper into the New York market - Stock Titan |
| 2022-11-02 | +6.4% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2021-07-08 | -6.2% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2021-08-05 | -5.7% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2024-05-10 | -5.5% | legal | Seeking Alpha | Nephros files $50M mixed securities shelf |
| 2024-05-10 | -5.5% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q1 2024 Earnings Call Transcript |
| 2022-08-10 | -5.5% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2023-11-01 | -5.4% | executive | Seeking Alpha | Nephros hires Judy Krandel as Chief Financial Officer |
| 2022-07-06 | +5.1% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2022-01-13 | -4.9% | legal | SEC EDGAR | NEPH 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-11-06 | +4.9% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q3 2022 Earnings Call Transcript |
| 2023-11-10 | +4.7% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q3 2023 Earnings Call Transcript |
| 2026-04-01 | -4.5% | news | GlobeNewswire | Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise |
| 2026-04-01 | -4.5% | news | Stock Titan | Hospitals get a new water safety planning option from Nephros - Stock Titan |
| 2023-03-02 | +4.3% | expansion | Seeking Alpha | Nephros and Donastar enter new strategic partnership |
| 2021-07-12 | +4.2% | legal | SEC EDGAR | NEPH 8-K: 1.01, 3.02 (SEC Filing) |
| 2021-10-08 | +4.1% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2024-05-09 | -3.9% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2025-03-04 | +3.7% | legal | SEC EDGAR | NEPH 8-K: 5.02 (SEC Filing) |
| 2023-01-11 | +3.6% | earnings | Seeking Alpha | Nephros guides Q4 and FY22 revenue slightly below estimates |
| 2023-01-11 | +3.6% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2022-08-23 | -3.5% | legal | SEC EDGAR | NEPH 8-K: 5.02 (SEC Filing) |
| 2024-11-08 | +3.3% | earnings | Seeking Alpha | Nephros reports Q3 results |
| 2026-03-05 | +3.2% | news | GlobeNewswire | Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call |
| 2025-05-08 | -3.1% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2024-11-13 | -3.1% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2022-10-11 | +3.0% | legal | SEC EDGAR | NEPH 8-K: 1.01, 2.02 (SEC Filing) |
| 2026-02-18 | -3.0% | news | Simply Wall St. | Aureus Greenway Holdings And 2 Other Promising Penny Stocks To Watch |
| 2023-05-03 | +2.8% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Nephros (NEPH) - Zacks Investment Research |
| 2023-05-11 | -2.4% | legal | SEC EDGAR | NEPH 8-K: 5.02 and (SEC Filing) |
| 2026-03-25 | -2.4% | executive | Stock Titan | Nephros (NASDAQ: NEPH) CEO exercises options for 120K shares - Stock Titan |
| 2024-08-10 | -2.1% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript |
| 2022-11-21 | -2.0% | legal | SEC EDGAR | NEPH 8-K: 2.01 and (SEC Filing) |
| 2026-03-28 | -1.7% | news | The Globe and Mail | Nephros Releases Updated 2026 Corporate Investor Presentation - The Globe and Mail |
| 2026-03-27 | -1.7% | news | Stock Titan | Nephros (NASDAQ: NEPH) shares updated 2026 corporate presentation with market - Stock Titan |
| 2025-04-28 | -1.7% | legal | SEC EDGAR | NEPH 8-K: 5.02 (SEC Filing) |
| 2026-04-08 | +1.5% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | Is Nephros (NEPH) Stock Stable Now | NEPH Q4 Earnings: Beats Estimates by $0.07 - Upside Surprise - Cổng thông tin điện tử Tỉnh Sơn La |
| 2022-02-23 | +1.4% | legal | SEC EDGAR | NEPH 8-K: 2.02 and (SEC Filing) |
| 2026-04-15 | +1.4% | news | Cổng thông tin điện tử Tỉnh Sơn La | Nephros (NEPH) Stock: Technical Trend (Momentum Building) 2026-04-15 - Vega Volatility - Cổng thông tin điện tử Tỉnh Sơn La |
| 2021-05-20 | -1.4% | legal | SEC EDGAR | NEPH 8-K: 5.02 and 5.07 (SEC Filing) |
| 2025-04-25 | +1.3% | news | Stock Titan | NEPH Stock Price, News & Analysis | Nephros - Stock Titan |
| 2026-04-09 | +1.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Is Nephros (NEPH) Stock in a Downtrend | Price at $2.82, Down 3.09% - Community Breakout Alerts - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-02-06 | +1.2% | news | simplywall.st | Nephros, Inc.'s (NASDAQ:NEPH) Popularity With Investors Under Threat As Stock Sinks 28% - simplywall.st |
| 2024-05-24 | -1.2% | legal | SEC EDGAR | NEPH 8-K: 5.02, 5.07 (SEC Filing) |
| 2023-05-10 | +1.1% | earnings | Seeking Alpha | Nephros GAAP EPS of -$0.03 misses by $0.01, revenue of $3.7M beats by $0.02M |
| 2022-09-08 | +1.1% | legal | SEC EDGAR | NEPH 8-K: 5.02 and (SEC Filing) |
| 2026-04-10 | -0.9% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | How does earnings affect Nephros (NEPH) Stock | Price at $3.02, Up 3.61% - Retail Flow - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-03 | -0.8% | news | UBND thành phố Hải Phòng | NEPH Stock Analysis: Nephros Inc. 2.21% Dip to $2.87 Med Device Performance Check - UBND thành phố Hải Phòng |
| 2021-09-02 | -0.8% | legal | SEC EDGAR | NEPH 8-K: 8.01 and (SEC Filing) |
| 2024-02-17 | +0.6% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-11-09 | -0.1% | earnings | Seeking Alpha | Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript |
| 2026-03-18 | -0.0% | news | Stock Titan | Director Arthur Amron receives 3,610 Nephros (NEPH) shares - Stock Titan |
| 2026-03-18 | -0.0% | news | Stock Titan | [Form 4] NEPHROS INC Insider Trading Activity - Stock Titan |